Comment on

• No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials.

  Gale RE, Hills R, Kottaridis PD, Srirangan S, Wheatley K, Burnett AK, Linch DC. Gale RE, et al. Blood. 2005 Nov 15;106(10):3658-65. doi: 10.1182/blood-2005-03-1323. Epub 2005 Aug 2. Blood. 2005. PMID: 16076872
• Role of allogeneic stem cell transplantation in FLT3/ITD-positive AML.

  Meshinchi S, Arceci RJ, Sanders JE, Smith FO, Woods WB, Radich JP, Alonzo TA. Meshinchi S, et al. Blood. 2006 Jul 1;108(1):400; author reply 400-1. doi: 10.1182/blood-2005-12-4938. Blood. 2006. PMID: 16790584 No abstract available.